Page last updated: 2024-08-17

acetopyrrothine and Angiogenesis, Pathologic

acetopyrrothine has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishizuka, M; Kawada, M; Kumagai, H; Masuda, T; Minamiguchi, K; Takeuchi, T1

Other Studies

1 other study(ies) available for acetopyrrothine and Angiogenesis, Pathologic

ArticleYear
Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis.
    International journal of cancer, 2001, Aug-01, Volume: 93, Issue:3

    Topics: Animals; Antifungal Agents; Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Female; Humans; Immunoblotting; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Paxillin; Peptides; Phosphoproteins; Platelet Aggregation Inhibitors; Precipitin Tests; Pyrrolidinones; Receptors, Vitronectin; Tumor Cells, Cultured; Umbilical Veins; Vitronectin

2001